ezetimibe has been researched along with cangrelor in 1 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (cangrelor) | Trials (cangrelor) | Recent Studies (post-2010) (cangrelor) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 418 | 54 | 286 |
| Protein | Taxonomy | ezetimibe (IC50) | cangrelor (IC50) |
|---|---|---|---|
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | 0.0004 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 0.0043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamska, U; Adamski, P; Koziński, M; Kubica, J; Ostrowska, M | 1 |
1 review(s) available for ezetimibe and cangrelor
| Article | Year |
|---|---|
New directions for pharmacotherapy in the treatment of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Antibodies, Monoclonal; Anticholesteremic Agents; Clinical Trials as Topic; Drug Discovery; Ezetimibe; Humans; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Treatment Outcome | 2016 |